<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="review-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rehab</journal-id><journal-title-group><journal-title xml:lang="ru">Реабилитология</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of Medical Rehabilitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2949-5873</issn><issn pub-type="epub">2949-5881</issn><publisher><publisher-name>IRBIS Publishing House (IRBIS LLC)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2949-5873/rehabil.2023.4</article-id><article-id custom-type="elpub" pub-id-type="custom">rehab-16</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group></article-categories><title-group><article-title>Реабилитация онкологических больных: сравнительный анализ клинических рекомендаций по ведению пациентов с раком паренхимы почек, раком мочевого пузыря и онкогинекологическими заболеваниями в России, Европе и США</article-title><trans-title-group xml:lang="en"><trans-title>Rehabilitation of oncological patients: a comparative analysis of clinical guidelines for managing oncological patients with renal parenchyma cancer, bladder cancer and female cancer in Russia, Europe, and USA</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5849-5585</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петренко</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrenko</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Петренко Дарья Андреевна</p><p>Ул. Трубецкая, д. 8/2, Москва 119048</p></bio><bio xml:lang="en"><p>Петренко Дарья Андреевна</p><p>8/2 Trubetskaya Str., Moscow 119048</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9212-3865</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Александров</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Aleksandrov</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Александров Андрей Георгиевич - к.б.н. Scopus Author ID: 57211350219.</p><p>Ул. Трубецкая, д. 8/2, Москва 119048; ул. Садовая-Триумфальная, д. 4/10, Москва 127006</p></bio><bio xml:lang="en"><p>Andrey G. Aleksandrov - PhD. Scopus Author ID: 57211350219.</p><p>8/2 Trubetskaya Str., Moscow 119048; 4/10 Sadovaya-Triumfalnaya Str., Moscow 127006</p></bio><email xlink:type="simple">andrey.alexandrov@ipsom.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное автономное образовательное учреждение высшего образования «Первый Московский государственный медицинский университет им. И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральное государственное автономное образовательное учреждение высшего образования «Первый Московский государственный медицинский университет им. И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет); Институт Превентивной и Социальной Медицины</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov University; Institute for Preventive and Social Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>06</day><month>09</month><year>2024</year></pub-date><volume>1</volume><issue>1</issue><fpage>80</fpage><lpage>88</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Петренко Д.А., Александров А.Г., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Петренко Д.А., Александров А.Г.</copyright-holder><copyright-holder xml:lang="en">Petrenko D.A., Aleksandrov A.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rehabilitology.com/jour/article/view/16">https://www.rehabilitology.com/jour/article/view/16</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Современная медицина уделяет существенное внимание комплексному подходу к ведению онкологических больных, от этапа диагностики до реабилитации. Для поддержания должного качества жизни пациентов и стандартизации клинических протоколов в соответствующие клинические рекомендации (КР) добавляют разделы, посвященные реабилитации. Ввиду разных уровней медицины в Европе, России и США актуальным является анализ КР по ведению пациентов онкологического профиля на этапе реабилитации.</p></sec><sec><title>Цель</title><p>Цель: провести сравнительный анализ КР по ведению пациентов онкологического профиля.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Поиск и отбор публикаций проведен по схеме PRISMA. В научных базах данных PubMed/MEDLINE, Google Scholar, ScienceDirect, научной библиотеке eLibrary, а также в поисковых системах Яндекс, Google и Рубрикаторе КР Минздрава России обнаружено в общей сложности 725 источников. После процедуры отбора в обзор включено 30 публикаций и КР.</p></sec><sec><title>Результаты</title><p>Результаты. Программы реабилитации представлены во многих российских, американских и европейских КР, посвященных онкологическим заболеваниям. В отечественных КР по ведению пациентов с раком паренхимы почек и раком мочевого пузыря сделан существенный акцент на пререабилитации и использовании подхода fast-track. Немало внимания уделено лечебной физической культуре и инструментальным методам. Американские и европейские руководства более детализированы, в частности представлены протоколы коррекции отдельных нежелательных явлений, значительную роль играют психологическая помощь и комплексная реабилитация. Отмечено отсутствие специализированной программы реабилитации в российских КР по ведению пациенток онкогинекологического профиля, представленные протоколы носят общий характер. Согласно зарубежным КР к реабилитации таких больных применяется мультидисциплинарный и персонифицированный подход в специализированных центрах.</p></sec><sec><title>Заключение</title><p>Заключение. Анализ показал ряд недостатков в российских КР. В отдельных руководствах не уделяется должного внимания оказанию реабилитации. Необходимо расширять мультидисциплинарный подход к реабилитации пациентов онкологического профиля, а также доказательную базу для улучшения отечественных КР.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Backround</title><p>Backround. Current medicine pays significant attention to an integrated approach in managing cancer patients, from the stage of diagnosis to rehabilitation. Sections on rehabilitation have been added to respective guidelines to maintain the proper quality of life of patients and standardization of clinical protocols. Due to the different levels of medicine in Europe, Russia and USA, it is important to analyze guidelines for supporting oncological patients at the rehabilitation stage.</p></sec><sec><title>Objective</title><p>Objective: to conduct a comparative analysis of guidelines for managing cancer patients.</p></sec><sec><title>Material and methods</title><p>Material and methods. The search and selection of publications were performed according to PRISMA recommendations. In scientific databases PubMed/MEDLINE, Google Scholar, ScienceDirect, eLibrary as well as via search engines and the Rubricator of Clinical Guidelines of the Ministry of Health of Russia, 725 sources were found. After the selection procedure, 30 publications and guidelines were included in the review.</p></sec><sec><title>Results</title><p>Results. Rehabilitation programs are presented in many Russian, American and European guidelines for the support of cancer patients. In Russian guidelines for managing patients with renal parenchyma and bladder cancer, a significant emphasis is made on the pre-rehabilitation and using fast-track approach. A lot of attention is paid to therapeutic physical culture and instrumental methods. American and European guidelines are more detailed, in particular, protocols for the correction of certain adverse events are presented, psychological assistance and complex rehabilitation play an essential role. The absence of specialized rehabilitation program in Russian clinical guidelines for supporting oncogynecological patients, and universal character of protocols were noted. According to foreign guidelines, the rehabilitation of such patients is multidisciplinary and personalized, and is carried out in specialized centers.</p></sec><sec><title>Conclusion</title><p>Conclusion. The review showed a number of deficiencies in Russian clinical guidelines. In certain documents, due attention is not paid to the provision of rehabilitation. It’s necessary to expand multidisciplinary approach in cancer patients' rehabilitation as well as the evidence base to improve Russian guidelines.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>Клинические рекомендации</kwd><kwd>КР</kwd><kwd>рак паренхимы почек</kwd><kwd>рак мочевого пузыря</kwd><kwd>онкогинелогические заболевания</kwd><kwd>реабилитация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Clinical guidelines</kwd><kwd>renal parenchyma cancer</kwd><kwd>bladder cancer</kwd><kwd>gynecologic oncology</kwd><kwd>rehabilitation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Mayer R.S., Engle J. Rehabilitation of individuals with cancer. Ann Rehabil Med. 2022; 46 (2): 60–70. https://doi.org/10.5535/arm.22036.</mixed-citation><mixed-citation xml:lang="en">Mayer R.S., Engle J. Rehabilitation of individuals with cancer. Ann Rehabil Med. 2022; 46 (2): 60–70. https://doi.org/10.5535/arm.22036.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Restaino S., Paglietti C., Arcieri M., et al. Management of patients diagnosed with endometrial cancer: comparison of guidelines. Cancers. 2023; 15 (4): 1091. https://doi.org/10.3390/cancers15041091.</mixed-citation><mixed-citation xml:lang="en">Restaino S., Paglietti C., Arcieri M., et al. Management of patients diagnosed with endometrial cancer: comparison of guidelines. Cancers. 2023; 15 (4): 1091. https://doi.org/10.3390/cancers15041091.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Власина А.Ю., Солопова А.Г., Иванов А.Е., Жалялова И.М. Оценка ранних проявлений постовариоэктомического синдрома у женщин с пограничными опухолями яичников. Акушерство, гинекология и репродукция. 2020; 14 (3): 269–82. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.125.</mixed-citation><mixed-citation xml:lang="en">Vlasina A.Yu., Solopova A.G., Ivanov A.E., Zhalyalova I.M. Assessment of early symptoms of surgical menopause in patients with borderline ovarian tumors. Obstetrics, Gynecology and Reproduction. 2020; 14 (3): 269–82 (in Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.125.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Солопова А.Г., Москвичёва В.С., Блбулян Т.А. и др. Актуальные вопросы профилактики, диагностики и лечения рака вульвы и влагалища. Акушерство, гинекология и репродукция. 2018; 12 (4): 62–70. https://doi.org/10.17749/2313-7347.2018.12.4.062-070.</mixed-citation><mixed-citation xml:lang="en">Solopova A.G., Moskvichyova V.S., Blbulyan T.A., et al. Topical issues of prevention, diagnosis and treatment of vulvar and vaginal cancer. Obstetrics, Gynecology and Reproduction. 2018; 12 (4): 62–70 (in Russ.). https://doi.org/10.17749/2313-7347.2018.12.4.062-070.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Санджиева Л.Н., Солопова А.Г., Блинов Д.В. и др. Сравнительный анализ качества жизни у пациенток с атипической гиперплазией и раком эндометрия при различных реабилитационных мероприятиях. Акушерство, гинекология и репродукция. 2022; 16 (4): 410–25. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2022.344.</mixed-citation><mixed-citation xml:lang="en">Sandzhieva L.N., Solopova A.G., Blinov D.V., et al. Comparatively analyzed quality of life in patients with atypical endometrial hyperplasia and endometrial cancer during various rehabilitation activities. Obstetrics, Gynecology and Reproduction. 2022; 16 (4): 410–25 (in Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2022.344.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Stout N.L., Santa Mina D., Lyons K.D., et al. A systematic review of rehabilitation and exercise recommendations in oncology guidelines. CA Cancer J Clin. 2021; 71 (2): 149–75. https://doi.org/10.3322/caac.21639.</mixed-citation><mixed-citation xml:lang="en">Stout N.L., Santa Mina D., Lyons K.D., et al. A systematic review of rehabilitation and exercise recommendations in oncology guidelines. CA Cancer J Clin. 2021; 71 (2): 149–75. https://doi.org/10.3322/caac.21639.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hellbom M., Bergelt C., Bergenmar M., et al. Cancer rehabilitation: a Nordic and European perspective. Acta Oncol. 2011; 50 (2): 179–86. https://doi.org/10.3109/0284186X.2010.533194.</mixed-citation><mixed-citation xml:lang="en">Hellbom M., Bergelt C., Bergenmar M., et al. Cancer rehabilitation: a Nordic and European perspective. Acta Oncol. 2011; 50 (2): 179–86. https://doi.org/10.3109/0284186X.2010.533194.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Идрисова Л.Э., Солопова А.Г., Ачкасов Е.Е. и др. Оценка влияния реабилитации на качество жизни онкогинекологических больных. Вопросы гинекологии, акушерства и перинатологии. 2019; 18 (6): 41–5. https://doi.org/10.20953/1726-1678-2019-6-41-45.</mixed-citation><mixed-citation xml:lang="en">Idrisova L.E., Solopova A.G., Achkasov E.E., et al. Assessment of the impact of rehabilitation on the quality of life of gynaecological oncology patients. Gynecology, Obstetrics and Perinatology. 2019; 18 (6): 41–5 (in Russ.). https://doi.org/10.20953/1726-1678-2019-6-41-45.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Блинов Д.В., Солопова А.Г., Плутницкий А.Н. и др. Организация здравоохранения в сфере реабилитации пациенток с онкологическими заболеваниями репродуктивной системы. ФАРМАКОЭКОНОМИКА Современная фармакоэкономика и фармакоэпидемиология. 2022; 15 (1): 119–30. https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.132.</mixed-citation><mixed-citation xml:lang="en">Blinov D.V., Solopova A.G., Plutnitskiy A.N., et al. Strengthening health care to provide rehabilitation services for women with cancer diseases of the reproductive system. FARMAKOEKONOMIKA. SOVREMENNAYA farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2022; 15 (1): 119–30 (in Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.132.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Блбулян Т.А., Солопова А.Г., Иванов А.Е., Куркина Е.И. Влияние послеоперационной реабилитации на качество жизни больных раком вульвы. Акушерство, гинекология и репродукция. 2020; 14 (4): 415–25. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.156.</mixed-citation><mixed-citation xml:lang="en">Blbulyan T.A., Solopova A.G., Ivanov A.E., Kurkina E.I. Effect of postoperative rehabilitation on quality of life in patients with vulvar cancer. Obstetrics, Gynecology and Reproduction. 2020; 14 (4): 415–25 (in Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.156.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Солопова А.Г., Блинов Д.В., Бегович Е. и др. Неврологические расстройства после гистерэктомии: от патогенеза к клинике. Эпилепсия и пароксизмальные состояния. 2022; 14 (1): 54–64. https://doi.org/10.17749/2077-8333/epi.par.con.2022.115.</mixed-citation><mixed-citation xml:lang="en">Solopova A.G., Blinov D.V., Begovich E., et al. Neurological disorders after hysterectomy: from pathogenesis to clinical manifestations. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2022; 14 (1): 54–64 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2022.115.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Солопова А.Г., Блинов Д.В., Демьянов С.В. и др. Эпигенетические аспекты реабилитации онкогинекологических больных. ФАРМАКОЭКОНОМИКА Современная фармакоэкономика и фармакоэпидемиология. 2022; 15 (2): 294–303. https://doi.org/10.17749/20704909/farmakoekonomika.2022.141.</mixed-citation><mixed-citation xml:lang="en">Solopova A.G., Blinov D.V., Demyanov S.V., et al. Epigenetic aspects in rehabilitation of female cancer patients. FARMAKOEKONOMIKA. SOVREMENNAYA farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2022; 15 (2): 294–303 (in Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.141.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Krychman M., Graham S., Bernick B., et al. The Women’s EMPOWER Survey: women’s knowledge and awareness of treatment options for vulvar and vaginal atrophy remains inadequate. J Sex Med. 2017; 14 (3): 425–33. https://doi.org/10.1016/j.jsxm.2017.01.011.</mixed-citation><mixed-citation xml:lang="en">Krychman M., Graham S., Bernick B., et al. The Women’s EMPOWER Survey: women’s knowledge and awareness of treatment options for vulvar and vaginal atrophy remains inadequate. J Sex Med. 2017; 14 (3): 425–33. https://doi.org/10.1016/j.jsxm.2017.01.011.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Seland M., Skrede K., Lindemann K., et al. Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer. Acta Obstet Gynecol Scand. 2022; 101 (3): 313–22. https://doi.org/10.1111/aogs.14310.</mixed-citation><mixed-citation xml:lang="en">Seland M., Skrede K., Lindemann K., et al. Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer. Acta Obstet Gynecol Scand. 2022; 101 (3): 313–22. https://doi.org/10.1111/aogs.14310.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">New Preferred Reporting Items for Systematic reviews and MetaAnalyses (PRISMA). URL: https://www.prisma-statement.org (дата обращения 17.05.2023).</mixed-citation><mixed-citation xml:lang="en">New Preferred Reporting Items for Systematic reviews and MetaAnalyses (PRISMA). Available at: https://www.prisma-statement.org (in Russ.) (accessed 17.05.2023).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Министерство здравоохранения РФ. Клинические рекомендации. Рак паренхимы почки. 2023. URL: https://cr.minzdrav.gov.ru/schema/10_4 (дата обращения 17.05.2023).</mixed-citation><mixed-citation xml:lang="en">Ministry of Health of the RF. Clinical guidelines. Renal parenchyma cancer. 2023. Available at: https://cr.minzdrav.gov.ru/schema/10_4 (in Russ.) (accessed 17.05.2023).</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">NCCN Clinical practice guidelines in oncology (NCCN Guidelines®). Distress management. URL: https://www.nccn.org/professionals/physician_gls/pdf/distress.pdf (дата обращения 17.05.2023).</mixed-citation><mixed-citation xml:lang="en">NCCN Clinical practice guidelines in oncology (NCCN Guidelines®). Distress management. Available at: https://www.nccn.org/professionals/physician_gls/pdf/distress.pdf (accessed 17.05.2023).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">NCCN Clinical practice guidelines in oncology (NCCN Guidelines®). Adult cancer pain. URL: https://www.nccn.org/professionals/physician_gls/pdf/pain.pdf (дата обращения 17.05.2023).</mixed-citation><mixed-citation xml:lang="en">NCCN Clinical practice guidelines in oncology (NCCN Guidelines®). Adult cancer pain. Available at: https://www.nccn.org/professionals/physician_gls/pdf/pain.pdf (accessed 17.05.2023).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">NCCN Clinical practice guidelines in oncology (NCCN Guidelines®). Cancer-related fatigue. URL: https://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdf (дата обращения 17.05.2023).</mixed-citation><mixed-citation xml:lang="en">NCCN Clinical practice guidelines in oncology (NCCN Guidelines®). Cancer-related fatigue. Available at: https://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdf (accessed 17.05.2023).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">EAU guidelines. Renal cell carcinoma. URL: https://uroweb.org/guidelines/renal-cell-carcinoma (дата обращения 17.05.2023).</mixed-citation><mixed-citation xml:lang="en">EAU guidelines. Renal cell carcinoma. Available at: https://uroweb.org/guidelines/renal-cell-carcinoma (accessed 17.05.2023).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Министерство здравоохранения РФ. Клинические рекомендации. Рак мочевого пузыря. 2023. URL: https://cr.minzdrav.gov.ru/schema/11_3 (дата обращения 17.05.2023).</mixed-citation><mixed-citation xml:lang="en">Ministry of Health of the RF. Clinical guidelines. Bladder cancer. 2023. Available at: https://cr.minzdrav.gov.ru/schema/11_3 (in Russ.) (accessed 17.05.2023).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">ASCO cancer treatment and survivorship care plans. URL: https://www.cancer.org/cancer/survivorship/long-term-health-concerns/survivorship-care-plans.html (дата обращения 17.05.2023).</mixed-citation><mixed-citation xml:lang="en">ASCO cancer treatment and survivorship care plans. Available at: https://www.cancer.org/cancer/survivorship/long-term-healthconcerns/survivorship-care-plans.html (accessed 17.05.2023).</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Министерство здравоохранения РФ. Клинические рекомендации. Рак тела матки и саркомы матки. 2021. URL: https://cr.minzdrav. gov.ru/schema/460_3 (дата обращения 17.05.2023).</mixed-citation><mixed-citation xml:lang="en">Ministry of Health of the RF. Clinical guidelines. Uterine body cancer and uterine sarcomas. 2021. Available at: https://cr.minzdrav.gov.ru/schema/460_3 (in Russ.) (accessed 17.05.2023).</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">German Guideline Program in Oncology. Endometrial cancer. Guideline (long version): URL: https://www.leitlinienprogrammonkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Endometriumkarzinom/GGPO_Endometrial_Cancer_2.0.pdf (дата обращения 17.05.2023).</mixed-citation><mixed-citation xml:lang="en">German Guideline Program in Oncology. Endometrial cancer. Guideline (long version): Available at: https://www. leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Endometriumkarzinom/GGPO_Endometrial_Cancer_2.0.pdf (accessed 17.05.2023).</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Министерство здравоохранения РФ. Клинические рекомендации. Рак яичников / рак маточной трубы / первичный рак брюшины. 2020. URL: https://cr.minzdrav.gov.ru/schema/547_2 (дата обращения 17.05.2023).</mixed-citation><mixed-citation xml:lang="en">Ministry of Health of the RF. Clinical guidelines. Ovarian cancer / fallopian tube cancer / primary peritoneal cancer. 2020. Available at: https://cr.minzdrav.gov.ru/schema/547_2 (in Russ.) (accessed 17.05.2023).</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Министерство здравоохранения РФ. Клинические рекомендации. Злокачественные новообразования влагалища. 2020. URL: https://cr.minzdrav.gov.ru/schema/344_1 (дата обращения 17.05.2023).</mixed-citation><mixed-citation xml:lang="en">Ministry of Health of the RF. Clinical guidelines. Malignant neoplasms of the vagina. 2020. Available at: https://cr.minzdrav.gov.ru/schema/344_1 (in Russ.) (accessed 17.05.2023).</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Министерство здравоохранения РФ. Клинические рекомендации. Рак вульвы. 2020. URL: https://cr.minzdrav.gov.ru/recomend/501_1 (дата обращения 17.05.2023).</mixed-citation><mixed-citation xml:lang="en">Ministry of Health of the RF. Clinical guidelines. Vulvar cancer. 2020. Available at: https://cr.minzdrav.gov.ru/recomend/501_1 (in Russ.) (accessed 17.05.2023).</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Министерство здравоохранения РФ. Клинические рекомендации. Пограничные опухоли яичников. 2020. URL: https://cr.minzdrav.gov.ru/schema/346_1 (дата обращения 17.05.2023).</mixed-citation><mixed-citation xml:lang="en">Ministry of Health of the RF. Clinical guidelines. Borderline ovarian tumors. 2020. Available at: https://cr.minzdrav.gov.ru/schema/346_1 (in Russ.) (accessed 17.05.2023).</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Министерство здравоохранения РФ. Клинические рекомендации. Рак молочной железы. 2021. URL: https://cr.minzdrav.gov.ru/schema/379_4 (дата обращения 17.05.2023).</mixed-citation><mixed-citation xml:lang="en">Ministry of Health of the RF. Clinical guidelines. Breast cancer. 2021. Available at: https://cr.minzdrav.gov.ru/schema/379_4 (in Russ.) (accessed 17.05.2023).</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Leitlinienprogramm onkologie. URL: https://www.leitlinienprogrammonkologie.de/home (на нем. яз.) (дата обращения 17.05.2023).</mixed-citation><mixed-citation xml:lang="en">Leitlinienprogramm onkologie. Available at: https://www.leitlinienprogramm-onkologie.de/home (in German) (accessed 17.05.2023).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
